MDT
Medtronic plc
Stock
$86.38−0.06 (−0.07%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8.0B | $7.3B | $7.0B | $6.8B | $6.0B | $7.3B | $6.2B | $7.2B | $7.0B | $4.7B | $6.9B | $5.2B | $4.9B | $5.0B | $4.9B |
| Capital expenditures | $1.9B | $1.9B | $1.9B | $1.6B | $1.5B | $1.4B | $1.4B | $1.2B | $1.1B | $1.1B | $1.3B | $1.0B | $571M | $396M | $457M |
| Free cash flow | $6.1B | $5.4B | $5.2B | $5.2B | $4.6B | $6.0B | $4.9B | $6.0B | $5.9B | $3.6B | $5.6B | $4.2B | $4.3B | $4.6B | $4.5B |
| Stock-based compensation | $496M | $457M | $429M | $393M | $355M | $359M | $344M | $297M | $290M | $344M | $348M | $375M | $439M | $145M | $152M |
| Buybacks | $1.2B | $1.0B | $3.2B | $2.1B | $645M | $2.5B | $652M | $1.3B | $2.9B | $2.2B | $3.5B | $2.8B | $1.9B | $2.6B | $1.2B |
| Dividends paid | $3.7B | $3.6B | $3.6B | $3.7B | $3.6B | $3.4B | $3.1B | $2.9B | $2.7B | $2.5B | $2.4B | $2.1B | $1.3B | $1.1B | $1.1B |
| Dividends per share | $2.85 | $2.84 | $2.80 | $2.76 | $2.72 | $2.52 | $2.32 | $2.16 | $2.00 | $1.84 | $1.72 | $1.52 | $1.22 | $1.12 | $1.04 |
| Free cash flow margin | 16.3% | 14.9% | 15.5% | 16.1% | 14.7% | 18.9% | 16.2% | 20.8% | 19.2% | 12.1% | 18.9% | 14.5% | 21.4% | 26.8% | 27.0% |